“…For early stage NSCLC, PDT is mainly used to treat endobronchial tumors, and for advanced or metastatic NSCLC and SCLC, PDT is mainly employed to alleviate symptoms from obstructing endobronchial lesions . However, most conventional PSs face the problem of aggregation-caused quenching (ACQ), for which both the fluorescence brightness and PDT effect are seriously hindered in the aggregate state. , In 2001, Tang et al first coined the aggregation-induced emission (AIE) concept, which represents a promising solution for the ACQ problem as both the emission and PDT properties of AIE luminogens (AIEgens) can be boosted in aggregate form. − Thus, AIEgen-based PSs hold great promise for PDT applications, especially in aggregate forms such as nanoparticles (NPs). − Tetraphenyl ethylene (TPE) is the most widely used building block for constructing AIEgens. − Although effective, TPE still faces some obstacles. For example, the highly twisted structure of TPE leads to a weak absorption capability (the absorption coefficients of TPE-based AIEgens are usually lower than 1.5 × 10 4 M –1 cm –1 ), and the weak electron-donating ability usually results in a short response wavelength. , Therefore, the development of new AIEgens with strong absorption ability and bright fluorescence in the deep red and near-infrared (NIR) region as well as a potent PDT property is highly desirable.…”